IMPACT OF DIABETES ON TUBERCULOSIS TREATMENT OUTCOMES: EDITORIAL PERSPECTIVE
DOI:
https://doi.org/10.70765/sd84he64Keywords:
tuberclousis, management, treatment, ageAbstract
Diabetes mellitus (DM) significantly alters tuberculosis (TB) treatment outcomes due to immune dysfunction, drug interactions, and limited access to integrated care. The coexistence of these conditions exacerbates global health disparities, particularly in low-resource settings. Diabetic patients with TB frequently exhibit delayed sputum conversion, higher relapse rates, and poorer cure outcomes than non-diabetic counterparts. Addressing these challenges requires an interdisciplinary approach combining better glycemic control, robust healthcare integration, and patient education. This editorial evaluates the interplay between DM and TB, discusses barriers to effective treatment, and highlights strategies to improve cure rates, advocating for targeted interventions to reduce the dual disease burden globally.
Downloads
References
1.World Health Organization. Collaborative Framework for Care and Control of Tuberculosis and Diabetes. Geneva: WHO; 2021.
2.Chiang CY, Lee JJ, et al. (2023). “Diabetes Mellitus and Tuberculosis: Impact on Treatment and Outcomes.” American Journal of Respiratory and Critical Care Medicine.
3.Kumar A, et al. (2022). “The Effect of Glycemic Control on Tuberculosis Treatment Outcomes.” International Journal of Tuberculosis and Lung Disease.
4.Harries AD, et al. (2016). “Tuberculosis and Diabetes Mellitus: Interactions, Impacts, and Policy Implications.” Annals of the New York Academy of Sciences.
5.Dooley KE, Chaisson RE. (2009). “Tuberculosis and Diabetes Mellitus: Convergence of Two Epidemics.” The Lancet Infectious Diseases. DOI: https://doi.org/10.1016/S1473-3099(09)70282-8
6.Jeon CY, Murray MB. (2008). “Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies.” PLoS Medicine. DOI: https://doi.org/10.1371/journal.pmed.0050181
7.Basit A, et al. (2023). "Integrated Management of TB and Diabetes: Success Stories and Lessons Learned." Journal of Global Health Reports.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 dr danyal (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
